Sun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company Limited, commonly referred to as SPARC, is a prominent player in the pharmaceutical industry, headquartered in India. Established in 2007, SPARC focuses on innovative drug development, particularly in the areas of dermatology, oncology, and complex generics. The company has made significant strides in research and development, with a commitment to enhancing patient care through unique formulations and delivery systems.
With a strong operational presence in India and a growing footprint in global markets, SPARC has achieved notable milestones, including successful collaborations and product approvals. Its core offerings, which include proprietary drug delivery technologies and specialty pharmaceuticals, set it apart in a competitive landscape. As a subsidiary of Sun Pharmaceutical Industries, SPARC is well-positioned to leverage its parent company's extensive resources and market reach, solidifying its reputation as a leader in advanced pharmaceutical research.
-25 vs industry average
Sun Pharma Advanced Research Company Limited’s score of 15 is lower than 12% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Sun Pharma Advanced Research Company Limited?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Sun Pharma Advanced Research Company Limited yet.
Sun Pharma Advanced Research Company Limited's reported carbon emissions
Sun Pharma Advanced Research Company Limited, headquartered in India, currently does not have available data on its carbon emissions, as indicated by the absence of specific emissions figures. Consequently, there are no reported Scope 1, Scope 2, or Scope 3 emissions totals.
The company has not outlined any specific reduction targets or climate commitments, nor does it appear to be part of initiatives such as the Science Based Targets initiative (SBTi) or similar climate pledges. This lack of data suggests that Sun Pharma Advanced Research Company Limited may still be in the early stages of formalising its climate strategy or reporting on its environmental impact.
As the global focus on sustainability intensifies, it is crucial for companies like Sun Pharma Advanced Research Company Limited to establish clear emissions reduction goals and engage in transparent reporting to align with industry standards and stakeholder expectations.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Sun Pharma Advanced Research Company Limited’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Sun Pharma Advanced Research Company Limited yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Sun Pharma Advanced Research Company Limited
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project